Non-traditional or alternative medicine is becoming an increasingly attractive approach for the treatment of various inflammatory disorders. Among these alternatives approaches is the use of food derivatives, which have the advantage of being relatively nontoxic. Curcumin has been reported to possess antioxidant, anti-inflammatory, antiviral, and anti-cancer properties. Curcumin is a nonnutritive, nontoxic polyphenol natural product found in turmeric, a spice that has been used for centuries in India and elsewhere as an herbal medicinal treatment of wounds, jaundice, and rheumatoid arthritis. The large consumption of curcumin by the Indian population may help explain their relatively low (4 times less) incidence of Alzheimer’s disease compared to the U.S. population. Consequently, there has been extensive interest in the antioxidant properties of curcumin and the possibility of using it as therapeutic drugs in modern medicine.
Researchers at the University of New Mexico have developed methods of administering a therapeutically effective amount of curcumin derivatives to treat diseases. These methods which utilize curcumin derivatives are useful for treating any disease or condition characterized by inflammation, including Alzheimer’s disease, diabetes (particularly type 2 diabetes), cancer or a precancerous condition, cystic fibrosis, rheumatoid arthritis, asthma, inflammatory bowel disease, ulcerative colitis, atherosclerosis and stroke.
Name: Gregg Banninger